Skip to main content
S&P 5007,663.60+0.95%DOW52,538.72+0.91%NASDAQ26,377.47+1.13%BTC$78,586.00+1.65%ETH$2,605.82+6.74%GOLD$4,411.90+0.10%OIL$99.61-2.80%
Smart Investors Daily
OP

NASDAQ · OPRX

OptimizeRx Corporation

Healthcare · Medical - Healthcare Information Services

$7.18

Down-$0.04 (-0.56%)

Updated Sep 11, 2026, 3:16 PM

SID Score

4.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
259.66M
P/E ratio
7,647.53
Dividend yield
0.00%
52-week range
$4.54 – $9.08
Volume
108.19K
Avg. volume
304.06K

Price performance

OPRX price history

1M range · 20 trading sessions · Daily adjusted prices

OPRX closed at $7.18 after 20 trading sessions, down 18.22% for the selected period.

Last close
$7.18
Period change
-18.22%
Period low
$7.17
Period high
$8.78
Daily close
View OHLC price history
OPRX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 10, 2026$7.07$7.26$6.86$7.18108.19K
Sep 9, 2026$7.60$7.60$7.16$7.1778.51K
Sep 8, 2026$7.84$7.84$7.56$7.6099.96K
Sep 4, 2026$7.84$7.90$7.66$7.8782.18K
Sep 3, 2026$8.09$8.335$7.90$7.95157.81K
Sep 2, 2026$7.93$8.3499$7.48$8.04171.64K
Sep 1, 2026$7.995$8.03$7.70$7.86115.54K
Aug 31, 2026$7.89$8.04$7.7086$7.98170.85K
Aug 28, 2026$7.83$8.09$7.60$7.95271.58K
Aug 27, 2026$7.75$8.00$7.65$7.83333.75K
Aug 26, 2026$7.78$7.85$7.62$7.75112.88K
Aug 25, 2026$7.66$7.935$7.59$7.86132.03K
Aug 24, 2026$7.71$8.10$7.60$7.65150.32K
Aug 21, 2026$8.21$8.215$7.59$7.71131.49K
Aug 20, 2026$7.98$8.2399$7.86$7.96194.89K
Aug 19, 2026$8.31$8.89$8.01$8.01208.04K
Aug 18, 2026$8.40$8.71$8.18$8.23217.02K
Aug 17, 2026$8.71$8.82$8.43$8.48139.52K
Aug 14, 2026$8.72$9.08$8.4505$8.72386.07K
Aug 13, 2026$6.82$8.90$6.58$8.781.13M

Latest OPRX news

The latest Smart Investors Daily articles mentioning OPRX.

Stock researchCompany · Overview

OPRX research

Overview

Company profile and research snapshot.

Company profile

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$23.00
Implied upside
—
Analysts
—
OPRX recent ratings
DateFirmRatingTarget
Aug 14, 2026CitizensMarket Outperform—
May 13, 2026Lake StreetBuy—
May 13, 2026Stephens & Co.Equal-Weight—
May 13, 2026B. Riley SecuritiesBuy—
May 13, 2026StifelBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 8, 2026

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced that management will participate in the 10th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September 10, 2026, in New York, NY. To request a meeting or for more details about the

Yahoo · Sep 2, 2026

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

Experienced pharmaceutical and healthcare executive joins advisory board to help accelerate innovation and strengthen life sciences marketing technologyWALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced the appointment of Troy Sarich as a Company advisor. Sarich

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By